Outcomes in African Americans and Hispanics with lupus nephritis

Kidney International

Volumn 69, Issue 10, 2006, Pages 1846-1851

  Contreras, G ^a   Lenz, O ^a   Pardo, V ^b   Borja, E ^a   Cely, C ^a   Iqbal, K ^a   Nahar, N ^a   De La Cuesta, C ^a   Hurtado, A ^a   Fornoni, A ^a   Beltran Garcia, L ^a   Asif, A ^a   Young, L ^a   Diego, J ^a   Zachariah, M ^a   Smith Norwood, B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

African Americans; Hispanics; Lupus nephritis

Indexed keywords

CREATININE;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CREATININE BLOOD LEVEL; DEATH; DISEASE CLASSIFICATION; ETHNOLOGY; FEMALE; HEMATOCRIT; HISPANIC; HUMAN; INCOME; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; UREMIA; WORLD HEALTH ORGANIZATION CLASSIFICATION;

ADOLESCENT; ADULT; AFRICAN AMERICANS; BLOOD PRESSURE; CASE-CONTROL STUDIES; COHORT STUDIES; CREATININE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCOME; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33646679637     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000243     Document Type: Article

References (30)

1. Cameron JS. Lupus nephritis. J Am Soc Nephrol 1999; 10: 413-424.
2. Pollak VE, Pirani CL, Schwartz FD. The natural history of the renal manifestations of systemic lupus erythematosus. J Lab Clin Med 1964; 63: 537-550.
3. Estes D, Christian C. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1975; 50: 85-95.
4. Appel GB, Cohen DJ, Pirani CL et al. Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med 1987; 83: 877-885.
5. Ward MM. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis. Am J Kidney Dis 2000; 36: 516-525.
6. Alarcon GS, McGwin Jr G, Petri M et al. Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 2002; 11: 95-101.
7. Austin III HA, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant 1995; 10: 1620-1628.
8. Bastian HM, Roseman JM, McGwin Jr G et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002; 11: 152-160.
9. Dooley MA, Hogan S, Jennette C, Falk R. Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int 1997; 51: 1188-1195.
10. Bakir AA, Levy PS, Dunea G. The prognosis of lupus nephritis in African-Americans: a retrospective analysis. Am J Kidney Dis 1994; 24: 159-171.
11. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 1991; 91: 345-353.
12. Alarcon GS, Roseman J, Bartolucci AA et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998; 41: 1173-1180.
13. Alarcon GS, McGwin Jr G, Bastian HM et al. Systemic lupus erythematosus in three ethnic groups. VII (correction of VIII). Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum 2001; 45: 191-202.
14. Miettunen PM, Ortiz-Alvarez O, Petty RE et al. Gender and ethnic origin have no effect on longterm outcome of childhood-onset systemic lupus erythematosus. J Rheumatol 2004; 31: 1650-1654.
15. Seligman VA, Lum RF, Olson JL et al. Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med 2002; 112: 726-729.
16. Nossent JC, Bronsveld W, Swaak AJ. Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 1989; 48: 810-816.
17. Vitali C, Bencivelli W, Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10: 527-539.
18. Gudmundsson S, Steinsson K. Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population. J Rheumatol 1990; 17: 1162-1167.
19. Nossent JC. Systemic lupus erythematosus on the Caribbean island of Curacao: an epidemiological investigation. Ann Rheum Dis 1992; 51: 1197-1201.
20. Lee SS, Li CS, Li PC. Clinical profile of Chinese patients with systemic lupus erythematosus. Lupus 1993; 2: 105-109.
21. Alballa SR. Systemic lupus erythematosus in Saudi patients. Clin Rheumatol 1995; 14: 342-346.
22. Barr RG, Seliger S, Appel GB et al. Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrol Dial Transplant 2003; 18: 2039-2046.
23. Reveille JD, Moulds JM, Ahn C et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum 1998; 41: 1161-1172.
24. Arbuckle MR, James JA, Dennis GJ et al. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus 2003; 12: 99-106.
25. Nelson KM, Chapko MK, Reiber G, Boyko EJ. The association between health insurance coverage and diabetes care; data from the 2000 Behavioral Risk Factor Surveillance System. Health Serv Res 2005; 40: 361-372.
26. Lopez R. Income inequality and self-rated health in US metropolitan areas: a multi-level analysis. Soc Sci Med 2004; 59: 2409-2419.
27. Betancourt JR, Maina AW. The Institute of Medicine report 'Unequal Treatment': implications for academic health centers. Mt Sinai J Med 2004; 71: 314-321.
28. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
29. Churg J, Bernstein J, Glassock RJ. Lupus nephritis, lupus-like syndrome, antiphospholipid antibody syndrome. In: Churg J, Bernstein J, Glassock RJ (eds). Renal disease: Classification and Atlas of Glomerular Disease. 2nd edn. New York: Igaku-Shoin, 1995, pp 151-179.
30. Austin III HA, Muenz LR, Joyce KM et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984; 25: 689-695.